| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Gastrointestinal Microbiome | 14 | 2020 | 1961 | 2.51 | Why? |
| Non-alcoholic Fatty Liver Disease | 11 | 2019 | 907 | 2.00 | Why? |
| Liver | 9 | 2020 | 4007 | 1.38 | Why? |
| Liver Diseases, Alcoholic | 2 | 2017 | 101 | 1.26 | Why? |
| Intestines | 4 | 2018 | 817 | 1.21 | Why? |
| Microbiota | 3 | 2018 | 1240 | 1.01 | Why? |
| Ethanol | 2 | 2017 | 533 | 0.92 | Why? |
| Liver Diseases | 5 | 2020 | 2698 | 0.88 | Why? |
| Acute-Phase Proteins | 2 | 2020 | 177 | 0.85 | Why? |
| Neopterin | 1 | 2021 | 69 | 0.84 | Why? |
| Liver Neoplasms | 5 | 2019 | 1666 | 0.78 | Why? |
| Esophageal and Gastric Varices | 2 | 2020 | 117 | 0.77 | Why? |
| Paneth Cells | 1 | 2018 | 8 | 0.74 | Why? |
| Growth Differentiation Factor 15 | 1 | 2018 | 89 | 0.73 | Why? |
| Verrucomicrobia | 1 | 2017 | 6 | 0.71 | Why? |
| Elasticity Imaging Techniques | 1 | 2020 | 194 | 0.71 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2020 | 238 | 0.71 | Why? |
| Fecal Microbiota Transplantation | 5 | 2021 | 372 | 0.70 | Why? |
| Liver Cirrhosis | 7 | 2019 | 1810 | 0.70 | Why? |
| Homeostasis | 2 | 2018 | 582 | 0.67 | Why? |
| Colorectal Neoplasms | 4 | 2018 | 1884 | 0.66 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.65 | Why? |
| Natural Killer T-Cells | 1 | 2018 | 191 | 0.64 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.63 | Why? |
| Leptin | 1 | 2017 | 141 | 0.61 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.61 | Why? |
| Insulin Resistance | 5 | 2018 | 669 | 0.61 | Why? |
| Lipocalin-2 | 1 | 2017 | 156 | 0.61 | Why? |
| Obesity | 8 | 2019 | 7388 | 0.59 | Why? |
| Food | 1 | 2018 | 316 | 0.58 | Why? |
| Gastrointestinal Tract | 2 | 2021 | 1113 | 0.57 | Why? |
| Intestinal Diseases | 1 | 2018 | 231 | 0.56 | Why? |
| Gastrointestinal Hemorrhage | 2 | 2020 | 669 | 0.55 | Why? |
| Feces | 5 | 2021 | 4235 | 0.55 | Why? |
| Interleukin-1 | 1 | 2017 | 438 | 0.53 | Why? |
| Carcinoma, Hepatocellular | 4 | 2019 | 1222 | 0.53 | Why? |
| Intestinal Mucosa | 4 | 2017 | 1046 | 0.52 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.51 | Why? |
| Austria | 8 | 2021 | 1259 | 0.50 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.49 | Why? |
| Inflammation | 6 | 2021 | 13255 | 0.47 | Why? |
| Receptors, Cytoplasmic and Nuclear | 2 | 2017 | 67 | 0.46 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.46 | Why? |
| Adipose Tissue | 1 | 2016 | 612 | 0.44 | Why? |
| Metabolic Diseases | 1 | 2016 | 505 | 0.43 | Why? |
| Bariatric Surgery | 2 | 2018 | 1298 | 0.36 | Why? |
| Inflammatory Bowel Diseases | 3 | 2020 | 3209 | 0.35 | Why? |
| Bile Acids and Salts | 2 | 2018 | 91 | 0.34 | Why? |
| Donor Selection | 4 | 2021 | 804 | 0.32 | Why? |
| Diet, High-Fat | 2 | 2017 | 161 | 0.31 | Why? |
| Diet | 2 | 2018 | 2052 | 0.31 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 40 | 0.31 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.30 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.30 | Why? |
| Diabetes Mellitus, Type 2 | 5 | 2019 | 6166 | 0.29 | Why? |
| Bone Diseases, Metabolic | 1 | 2005 | 64 | 0.29 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.28 | Why? |
| Adipocytes | 2 | 2019 | 173 | 0.26 | Why? |
| Hepatocytes | 2 | 2017 | 549 | 0.26 | Why? |
| Interferon Type I | 1 | 2016 | 2789 | 0.25 | Why? |
| Infliximab | 2 | 2018 | 502 | 0.25 | Why? |
| Animals | 17 | 2019 | 78931 | 0.25 | Why? |
| Colonic Neoplasms | 2 | 2017 | 295 | 0.25 | Why? |
| Hep G2 Cells | 3 | 2018 | 391 | 0.25 | Why? |
| Lipid Metabolism | 2 | 2019 | 572 | 0.25 | Why? |
| Postprandial Period | 2 | 2019 | 45 | 0.24 | Why? |
| Clostridium Infections | 2 | 2020 | 595 | 0.24 | Why? |
| Cytokines | 4 | 2020 | 15010 | 0.24 | Why? |
| Energy Metabolism | 3 | 2018 | 451 | 0.24 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.23 | Why? |
| Carrier Proteins | 1 | 2005 | 513 | 0.23 | Why? |
| Transferrin | 2 | 2018 | 90 | 0.22 | Why? |
| Glycoproteins | 1 | 2005 | 615 | 0.21 | Why? |
| Psoas Muscles | 1 | 2019 | 28 | 0.20 | Why? |
| Hemochromatosis | 1 | 2019 | 20 | 0.20 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.20 | Why? |
| Dystrophin-Associated Proteins | 1 | 2019 | 2 | 0.20 | Why? |
| Liver Transplantation | 4 | 2019 | 2864 | 0.20 | Why? |
| Tunicamycin | 1 | 2018 | 9 | 0.20 | Why? |
| Receptors, Somatotropin | 1 | 2018 | 8 | 0.20 | Why? |
| Repressor Proteins | 2 | 2018 | 232 | 0.19 | Why? |
| Spermidine | 1 | 2019 | 56 | 0.19 | Why? |
| Humans | 55 | 2021 | 930598 | 0.19 | Why? |
| Growth Hormone | 1 | 2018 | 29 | 0.19 | Why? |
| Interleukin-23 | 1 | 2019 | 64 | 0.19 | Why? |
| Liver Regeneration | 1 | 2018 | 38 | 0.18 | Why? |
| Ketone Bodies | 1 | 2018 | 53 | 0.18 | Why? |
| Analytic Sample Preparation Methods | 1 | 2017 | 5 | 0.18 | Why? |
| COUP Transcription Factors | 1 | 2017 | 1 | 0.18 | Why? |
| Dietary Fats | 1 | 2019 | 96 | 0.18 | Why? |
| Macrophages | 3 | 2021 | 2784 | 0.18 | Why? |
| Interleukin-12 | 1 | 2019 | 156 | 0.18 | Why? |
| Mice, Inbred C57BL | 3 | 2017 | 5542 | 0.18 | Why? |
| Adipogenesis | 1 | 2017 | 38 | 0.18 | Why? |
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 30 | 0.18 | Why? |
| Acrylamides | 1 | 2017 | 40 | 0.18 | Why? |
| Dihydroxyphenylalanine | 1 | 2017 | 10 | 0.18 | Why? |
| Subcutaneous Fat | 1 | 2018 | 94 | 0.18 | Why? |
| Paraganglioma, Extra-Adrenal | 1 | 2017 | 8 | 0.17 | Why? |
| Adipose Tissue, White | 1 | 2017 | 30 | 0.17 | Why? |
| Insulin-Like Growth Factor I | 1 | 2018 | 119 | 0.17 | Why? |
| 3-Iodobenzylguanidine | 1 | 2017 | 25 | 0.17 | Why? |
| Gastroplasty | 1 | 2016 | 20 | 0.17 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.17 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2017 | 83 | 0.17 | Why? |
| NAD | 1 | 2017 | 73 | 0.16 | Why? |
| Hypertension, Portal | 1 | 2017 | 73 | 0.16 | Why? |
| Fibroblast Growth Factors | 1 | 2017 | 119 | 0.16 | Why? |
| Gastrointestinal Agents | 2 | 2018 | 393 | 0.16 | Why? |
| Osteoporosis | 2 | 2017 | 410 | 0.16 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 130 | 0.16 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2018 | 253 | 0.16 | Why? |
| Enterocolitis, Pseudomembranous | 1 | 2017 | 93 | 0.16 | Why? |
| Membrane Glycoproteins | 1 | 2005 | 2273 | 0.15 | Why? |
| Obesity, Morbid | 2 | 2017 | 1340 | 0.15 | Why? |
| Biopsy | 3 | 2020 | 2811 | 0.15 | Why? |
| Gene Expression Regulation | 3 | 2017 | 4020 | 0.15 | Why? |
| Glucose Intolerance | 1 | 2016 | 115 | 0.15 | Why? |
| Benzhydryl Compounds | 1 | 2018 | 240 | 0.15 | Why? |
| Mice, Knockout | 2 | 2019 | 1815 | 0.14 | Why? |
| alpha 1-Antitrypsin | 1 | 2018 | 264 | 0.14 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.14 | Why? |
| Adult | 19 | 2021 | 244371 | 0.14 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.14 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2017 | 424 | 0.14 | Why? |
| Rectum | 1 | 2018 | 495 | 0.14 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2016 | 610 | 0.14 | Why? |
| Fatty Liver | 1 | 2018 | 299 | 0.14 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.14 | Why? |
| Adiposity | 1 | 2017 | 329 | 0.14 | Why? |
| Postoperative Period | 1 | 2016 | 651 | 0.14 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.14 | Why? |
| Sarcopenia | 1 | 2019 | 422 | 0.14 | Why? |
| Adenoma | 1 | 2017 | 215 | 0.14 | Why? |
| Colitis | 1 | 2017 | 266 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 502 | 0.13 | Why? |
| Interleukin-17 | 1 | 2019 | 602 | 0.13 | Why? |
| Glucosides | 1 | 2018 | 359 | 0.13 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.13 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.13 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.13 | Why? |
| Aged | 15 | 2021 | 215776 | 0.13 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.13 | Why? |
| Male | 22 | 2021 | 367725 | 0.13 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.13 | Why? |
| Pancreas | 1 | 2017 | 398 | 0.13 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.13 | Why? |
| Female | 22 | 2021 | 380317 | 0.13 | Why? |
| Adipokines | 2 | 2017 | 87 | 0.12 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.12 | Why? |
| Colon | 1 | 2018 | 669 | 0.12 | Why? |
| Search Engine | 1 | 2020 | 628 | 0.12 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.12 | Why? |
| Mice | 5 | 2019 | 21357 | 0.12 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.12 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.12 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.11 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.11 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.10 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Bacterial Physiological Phenomena | 1 | 2009 | 31 | 0.10 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2017 | 1061 | 0.10 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.10 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.10 | Why? |
| Endoscopy | 1 | 2020 | 1564 | 0.10 | Why? |
| Gastroenterology | 1 | 2020 | 1352 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2018 | 997 | 0.09 | Why? |
| Thinness | 1 | 2009 | 99 | 0.09 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 59 | 0.09 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.09 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2008 | 119 | 0.09 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.09 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2008 | 93 | 0.09 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.09 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Consensus | 2 | 2019 | 6345 | 0.08 | Why? |
| PPAR gamma | 1 | 2008 | 102 | 0.08 | Why? |
| Osteopontin | 1 | 2008 | 96 | 0.08 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.08 | Why? |
| Energy Intake | 1 | 2009 | 323 | 0.08 | Why? |
| Risk Adjustment | 2 | 2021 | 730 | 0.08 | Why? |
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 13 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Eating | 1 | 2009 | 395 | 0.08 | Why? |
| Osteoprotegerin | 1 | 2005 | 32 | 0.08 | Why? |
| RANK Ligand | 1 | 2005 | 47 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.08 | Why? |
| Neoplasm Staging | 3 | 2017 | 1999 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Cells, Cultured | 1 | 2016 | 5835 | 0.07 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.07 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.07 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.07 | Why? |
| Risk Factors | 9 | 2019 | 71621 | 0.07 | Why? |
| Lipopolysaccharides | 1 | 2009 | 848 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2019 | 2320 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2018 | 1969 | 0.07 | Why? |
| Young Adult | 4 | 2018 | 93724 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Specimen Handling | 2 | 2019 | 6190 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.06 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.06 | Why? |
| Area Under Curve | 2 | 2021 | 2564 | 0.06 | Why? |
| Bone Density | 1 | 2005 | 335 | 0.06 | Why? |
| Transcription Factors | 1 | 2008 | 784 | 0.06 | Why? |
| Internet | 1 | 2020 | 6204 | 0.06 | Why? |
| Chemokines | 1 | 2008 | 1095 | 0.06 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Gain of Function Mutation | 1 | 2019 | 54 | 0.05 | Why? |
| Prevalence | 5 | 2019 | 25773 | 0.05 | Why? |
| Cation Transport Proteins | 1 | 2019 | 53 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Frozen Sections | 1 | 2018 | 19 | 0.05 | Why? |
| Caveolin 1 | 1 | 2019 | 73 | 0.05 | Why? |
| Biomedical Research | 1 | 2019 | 5270 | 0.05 | Why? |
| Preoperative Period | 1 | 2019 | 271 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Glycocholic Acid | 1 | 2017 | 1 | 0.05 | Why? |
| Diet, Carbohydrate Loading | 1 | 2017 | 2 | 0.05 | Why? |
| Adipose Tissue, Beige | 1 | 2017 | 3 | 0.05 | Why? |
| Uncoupling Protein 1 | 1 | 2017 | 6 | 0.05 | Why? |
| Mucin-2 | 1 | 2017 | 5 | 0.05 | Why? |
| Tight Junction Proteins | 1 | 2017 | 16 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.05 | Why? |
| Timolol | 1 | 2017 | 11 | 0.04 | Why? |
| Desiccation | 1 | 2017 | 38 | 0.04 | Why? |
| Propanolamines | 1 | 2017 | 47 | 0.04 | Why? |
| Dextran Sulfate | 1 | 2017 | 54 | 0.04 | Why? |
| Adipose Tissue, Brown | 1 | 2017 | 20 | 0.04 | Why? |
| Dietary Sucrose | 1 | 2017 | 15 | 0.04 | Why? |
| Glucose-6-Phosphatase | 1 | 2017 | 5 | 0.04 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Mitochondrial Dynamics | 1 | 2017 | 30 | 0.04 | Why? |
| Carnitine O-Palmitoyltransferase | 1 | 2017 | 11 | 0.04 | Why? |
| Bacteria | 1 | 2009 | 1897 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.04 | Why? |
| Propranolol | 1 | 2017 | 36 | 0.04 | Why? |
| Glycogen | 1 | 2017 | 12 | 0.04 | Why? |
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 17 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Diet, Western | 1 | 2017 | 42 | 0.04 | Why? |
| Fructose | 1 | 2017 | 52 | 0.04 | Why? |
| Gene Knockdown Techniques | 1 | 2018 | 347 | 0.04 | Why? |
| Cell Size | 1 | 2017 | 106 | 0.04 | Why? |
| PPAR alpha | 1 | 2017 | 36 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Carbazoles | 1 | 2017 | 120 | 0.04 | Why? |
| Oxidative Stress | 1 | 2008 | 2050 | 0.04 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2017 | 126 | 0.04 | Why? |
| Chemoembolization, Therapeutic | 1 | 2017 | 144 | 0.04 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.04 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2017 | 222 | 0.04 | Why? |
| Sodium | 1 | 2018 | 309 | 0.04 | Why? |
| Graft Survival | 1 | 2019 | 587 | 0.04 | Why? |
| Serum Albumin, Human | 1 | 2018 | 265 | 0.04 | Why? |
| Withholding Treatment | 1 | 2021 | 798 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.04 | Why? |
| Living Donors | 1 | 2020 | 652 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2021 | 1475 | 0.03 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.03 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.03 | Why? |
| Chromatography, Liquid | 1 | 2017 | 640 | 0.03 | Why? |
| Triglycerides | 1 | 2017 | 478 | 0.03 | Why? |
| Early Medical Intervention | 1 | 2017 | 487 | 0.03 | Why? |
| Iron | 1 | 2019 | 619 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Catheter Ablation | 1 | 2017 | 438 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Water | 1 | 2017 | 765 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.03 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.03 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.03 | Why? |
| Diabetic Ketoacidosis | 1 | 2018 | 622 | 0.03 | Why? |
| Chronic Disease | 1 | 2005 | 5139 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.03 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.02 | Why? |
| Hospital Units | 1 | 2017 | 1017 | 0.02 | Why? |
| Disease Progression | 2 | 2019 | 13580 | 0.02 | Why? |
| Sex Characteristics | 1 | 2017 | 1120 | 0.02 | Why? |
| Anti-Inflammatory Agents | 1 | 2008 | 6153 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.02 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Laparoscopy | 1 | 2017 | 1532 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| China | 1 | 2019 | 50654 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |